# Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis

> **NCT05811403** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Cairo University** · enrollment: 64 (estimated)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **OTHER:** Epigallocatechin gallate (EGCG)
- **OTHER:** Sodium hypochlorite (NaOCl)
- **OTHER:** Mineral trioxide aggregate (MTA)
- **OTHER:** Premixed bioceramic putty

## Key facts

- **NCT ID:** NCT05811403
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05811403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05811403, "Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05811403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*